Yu J - Search Results

1

Delivery of EZH2-shRNA with mPEG-PEI nanoparticles for the treatment of prostate cancer in vitro.

Wu Y, Yu J, Liu Y, Yuan L, Yan H, Jing J, Xu G. Wu Y, et al. Among authors: yu j. Int J Mol Med. 2014 Jun;33(6):1563-9. doi: 10.3892/ijmm.2014.1724. Epub 2014 Apr 4. Int J Mol Med. 2014. PMID: 24714818

2

Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.

Lu YY, Jiang B, Zhao FJ, Cui D, Jiang Q, Yu JJ, Li EH, Wang XH, Han BM, Xia SJ. Lu YY, et al. Asian J Androl. 2013 Sep;15(5):672-8. doi: 10.1038/aja.2013.45. Epub 2013 Jun 24. Asian J Androl. 2013. PMID: 23792338 Free PMC article.

3

miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.

Yu J, Lu Y, Cui D, Li E, Zhu Y, Zhao Y, Zhao F, Xia S. Yu J, et al. Oncol Rep. 2014 Feb;31(2):910-8. doi: 10.3892/or.2013.2897. Epub 2013 Dec 5. Oncol Rep. 2014. PMID: 24317363

4

miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.

Yu JJ, Wu YX, Zhao FJ, Xia SJ. Yu JJ, et al. Med Oncol. 2014 Apr;31(4):910. doi: 10.1007/s12032-014-0910-y. Epub 2014 Mar 15. Med Oncol. 2014. PMID: 24633705

5

The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis.

Niu Q, Lu Y, Wu Y, Xu S, Shi Q, Huang T, Zhou G, Gu X, Yu J. Niu Q, et al. Among authors: yu j. Medicine (Baltimore). 2018 Jul;97(29):e11378. doi: 10.1097/MD.0000000000011378. Medicine (Baltimore). 2018. PMID: 30024509 Free PMC article.

6

Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study.

Niu Q, Lu Y, Xu S, Shi Q, Guo B, Guo Z, Huang T, Wu Y, Yu J. Niu Q, et al. Among authors: yu j. Cancer Manag Res. 2018 Oct 11;10:4479-4489. doi: 10.2147/CMAR.S175286. eCollection 2018. Cancer Manag Res. 2018. PMID: 30349380 Free PMC article.

7

Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion.

Xu SG, Yu JJ, Shi Q, Niu Q, Guo Z, Guo BY, Zhou GC, Gu X, Wu YX. Xu SG, et al. Oncol Rep. 2019 Jul;42(1):273-282. doi: 10.3892/or.2019.7157. Epub 2019 May 13. Oncol Rep. 2019. PMID: 31115564

8

Novel role of microRNAs in prostate cancer.

Yu JJ, Xia SJ. Yu JJ, et al. Chin Med J (Engl). 2013;126(15):2960-4. Chin Med J (Engl). 2013. PMID: 23924475 Review.

9

LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11.

Jiang CY, Yu JJ, Ruan Y, Wang XH, Zhao W, Wang XJ, Zhu YP, Gao Y, Hao KY, Chen L, Han BM, Xia SJ, Zhao FJ. Jiang CY, et al. Oncotarget. 2016 May 3;7(18):26247-58. doi: 10.18632/oncotarget.8359. Oncotarget. 2016. PMID: 27028859 Free PMC article.

10

Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of prostate cancer among men who underwent template-guided prostate biopsy: A STROBE-compliant study.

Huang TB, Mao SY, Lu SM, Yu JJ, Luan Y, Gu X, Liu H, Zhou GC, Ding XF. Huang TB, et al. Medicine (Baltimore). 2016 Nov;95(44):e5307. doi: 10.1097/MD.0000000000005307. Medicine (Baltimore). 2016. PMID: 27858908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,970 results

Search Page

Filters